GUIDE Sosiete

Njàngalem OMS ci IA ci Wérgi-yaram

Jàmm ci jàmmu gi ci AI ci yeneen jàmmu, jàmmu ci jàmmu, jàmmu ci jàmmu, jàmmu ci jàmmu, jàmmu ci jàmmu, jàmmu ci jàmmu, jàmmu ci jàmmu.

Déglul tegtal biiIA-nettali · ~3 min

Ci xët wii3 simili jàng
  1. Résumé
  2. Plongeur bu xóot
  3. Doxal ci àdduna dëgg
  4. Jàmmu ci yeneen jàmmu ci yeneen jàmmu.
  5. Teg ko ci jëf
  6. Weyal di banneexu
  7. Laaj yi ñuy faral di laaj

Résumé

Jàmmu ci yeneen jàmmu ci yeneen jàmmu ci yeneen jàmmu ci yeneen jàmmu ci yeneen jàmmu ci yeneen jàmmu.

Plongeur bu xóot

The World Health Organization’s guidance on ethics and governance of AI for health sets out principles for designing, developing, and using AI in ways that protect people and public interests. Its framework calls for human autonomy, safety and well-being, transparency, responsibility and accountability, inclusion and equity, and responsiveness and sustainability. These principles apply across the lifecycle, from deciding whether AI is appropriate to monitoring how it works in practice. WHO emphasizes that people should remain in control of healthcare systems and medical decisions, and that privacy and confidentiality should be protected. AI should be developed for well-defined use cases, with quality controls and meaningful information about design and limitations. Organizations should establish mechanisms for questioning decisions and redress when people are harmed. Inclusion requires attention to who benefits, who is left out, and how access is distributed. The guidance is normative and does not certify a product or replace national regulation. Health systems can use it to build governance: define accountability, engage patients and health workers, assess bias and safety, protect data, and monitor real-world use. WHO’s later guidance on large multimodal models applies similar principles to generative AI, urging careful evaluation and human oversight. Governance should be adapted to local law and health-system capacity. Consider procurement, workforce effects, and how patients can opt out or ask questions. Assign responsibility for responding when a system behaves unexpectedly.

Doxal ci àdduna dëgg

Jàmmu ci yeneen jàmmu ci AI ci yeneen jàmmu ci yeneen jàmmu ci yeneen jàmmu.

Jàmmu ci yeneen jàmmu ci yeneen jàmmu ci yeneen jàmmu ci yeneen jàmmu.

Jàmmu ci yeneen jàmmu ci yeneen jàmmu ci yeneen jàmmu.

Agsiñi bu jëmmal ci wàllu AI am na solo ngir jàmmal ci wàllu jàmm ci wàllu jàmm.

Jàmmu ci yeneen jàmmu ci yeneen jàmmu.

WHO and national bodies continue to develop guidance as new AI capabilities enter health systems. More capable generative models increase the importance of measuring benefit before routine use and maintaining privacy, accountability, and human oversight. Health organizations can build trust through transparent limits, community participation, and continuous evaluation. Ethical governance is an ongoing responsibility shared by developers, providers, governments, and affected people. Evidence of benefit and harm should inform revisions. Include feedback from affected communities and evaluate outcomes after system changes.

Teg ko ci jëf

Lu tax mu am solo

  • Risk ak kaaraange. Gaañ-gaañu IA yu mag yi ak yu bës bu nekk yépp a ngi aju ci ki xam risk yi ak ki mëna def dara.
  • dogal yu gëna leer. Liggéeyukaay ak xam-xam bu ñépp bokk mooy wane ndax politiku kaaraange bu dëgër mën na am ci wàllu politik.
  • Dagg ci hype. Faram-fàcce yu leer dañuy wàññi li ñuy jàpp ci hype, PR lab, ak tiyaatar bu leerul.

Moytul

  • Jàppale risku nekk gi ni siyaas fiksioŋ fekk kàttan gi dafay yokk.
  • Jaxasoo kaaraange produit surface ak jubluwaay ci suufu autonomie bu kawe.
  • Bàyyi nit ñi xamul làkku Àngle ak ñi xamul làkku Angale, ñu am balluwaay yu baaxul.

Jéego yi ci topp

  1. Tàqale loraange yi ci produit bi, jëfandikoo bu baaxul, ak risku ñàkka mëna yor / ñàkka méngoo.
  2. Laajteel ban firnde mooy soppi sa xalaat ci kalendriye yi ak tar gi.
  3. Danga taamu balluwaay yu njëkk yi ak jàngat yu fëgër yi moo gën waxtaanu njaay mi.
  4. Xaarandil benn yoonu jëf: liggéey, politik, xaalis, wala xam-xam — du xam-xam kese.

Weyal di banneexu

Bulletin bu amul fayda

Jàngal xibaar AI bu bes

Ñatti jaar-jaari IA yuñ firndeel bis bu nekk ci ayu-bis bi, ñu bind leen ci Àngle bu leer. Gratis ba fàww, amul yëgle.

Benn email bis bu nekk ci ayu-bis bi. Benn klik nga dindi abonemaa bi. Dunu musa jaay wala séddoo sa adres.

Nattal sa bopp

Take the WHO Guidance on AI in Health quiz

Feedback ci saasi ci bépp tontu, ak sertifikaa buñ mëna séddoo ak ID buñ mëna saytu soo jàllee ci njàng mi.

Tambalil quiz

Jàppale njàngum IA te doo fay. AI Understanding mbootaay la buy def te Yàlla tax — amul yëgle, amul paywall, musul am. Defal ab sarax

Laaj yi ñuy faral di laaj

What is WHO Guidance on AI in Health?

WHO guidance on AI in health emphasizes human rights, safety, transparency, accountability, inclusion, and ongoing evaluation. These are governance principles, not a product certification or a substitute for local law. Health systems should involve affected people, assess risks through the lifecycle, and ensure that AI supports rather than displaces human decision-making.

What does WHO’s AI-in-health guidance provide?

WHO guidance sets principles and recommendations, not product certification.

Is WHO guidance a product certification?

The guide distinguishes ethical principles from legal authorization.

Which disclosure most directly explains a health AI tool’s intended use, evidence, and limitations?

Transparency should help people understand the system and its use.

Who shares responsibility for ethical AI in health?

WHO frames governance as a shared stakeholder responsibility.